首页> 外文OA文献 >Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

【2h】

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

机译：Delamanid，Linezolid，Levofloxacin和吡嗪酰胺用于治疗含氟喹诺酮类敏感多药结核患者（使用现有和新药物治疗MDR-TB的治疗缩短）：研究协议II / III，多中心，随机，开放标签临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Myungsun Lee; Jeongha Mok; Deog Kyeom Kim; Tae Sun Shim; Won-Jung Koh; Doosoo Jeon; Taehoon Lee; Seung Heon Lee; Ju Sang Kim; Jae Seuk Park; Ji Yeon Lee; Song Yee Kim; Jae Ho Lee; Kyung-Wook Jo; Byung Woo Jhun; Young Ae Kang; Joong Hyun Ahn; Chang-Ki Kim; Soyoun Shin; Taeksun Song; Sung Jae Shin; Young Ran Kim; Heejung Ahn; Seokyung Hahn; Ho Jeong Won; Ji Yeon Jang; Sang Nae Cho; Jae-Joon Yim;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial [J] . Myungsun Lee, Jeongha Mok, Deog Kyeom Kim, Trials . 2019,第1期

机译：Delamanid，Linezolid，Levofloxacin和吡嗪酰胺用于治疗含氟喹诺酮类敏感多药结核患者（使用现有和新药物治疗MDR-TB的治疗缩短）：研究协议II / III，多中心，随机，开放标签临床试验
2. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open-label, phase II trial [J] . Ji Yeon Lee, Deog Kyeom Kim, Jung-Kyu Lee, Trials . 2017,第1期

机译：在肺结核强化治疗中用乙胺丁醇替代乙胺丁醇：一项前瞻性，多中心，随机，开放标签，II期试验的研究方案
3. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP) [J] . James A. Seddon, Anthony J. Garcia-Prats, Susan E. Purchase, Trials . 2018,第1期

机译：Levofloxacin与安慰剂用于预防多药抗性结核病儿童联系人的结核病疾病：研究方案III集群随机对照试验（TB-Champ）
4. Minimally invasive treatment of Benign Prostatic Hyperplasia with High Intensity Focused Ultrasound using the Sonablate~(TM) System: an updated report of Phase III clinical studies conducted in the USA [C] . Thomas A. Gardner, Michael O Koch, Arieh Shalhav, Conference on Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems Ⅻ Jan 19-20, 22, 2002 San Jose, USA . 2002

机译：使用Sonablate〜（TM）系统以高强度聚焦超声微创治疗良性前列腺增生：在美国进行的III期临床研究的最新报告
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Delamanid linezolid levofloxacin and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs MDR-END): study protocol for a phase II/III multicenter randomized open-label clinical trial [O] . Myungsun Lee, Jeongha Mok, Deog Kyeom Kim, 2019

机译：地拉曼尼利奈唑胺左氧氟沙星和吡嗪酰胺用于治疗氟喹诺酮敏感性耐多药结核病（使用现有药物和新药治疗MDR-TB缩短MDR-END）：II / III期多中心随机开放标签的临床试验
7. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open-label, phase II trial [O] . Ji Yeon Lee, Deog Kyeom Kim, Jung-Kyu Lee, 2017

机译：在肺结核强化治疗中用乙胺丁醇替代乙胺丁醇：一项前瞻性，多中心，随机，开放标签，II期试验的研究方案

著录项

引文网络

相似文献

相关主题

期刊订阅